Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Biotechnology Value Fund
3871
Biotechnology Value Fund
Suggest edits
Follow us
Also headquartered in San Francisco
Twitter
Uber
Instagram
Airbnb
Lyft
Fitbit
LinkedIn
Salesforce
TikTok
Reddit
Overview
News
Investments
13
Portfolio
Portfolio Tracker
Add info
Add round
22 Jul
2020
Olema Pharmaceuticals
$54,000,000
Venture capital (Series B)
Foresite Capital
,
RA Capital Management
,
Wellington Management
,
+6
Olema Oncology Secures $54 Million To Advance Lead Program In Breast Cancer
Pulse 2.0
11 Jun
2020
Autobahn Therapeutics
$76,000,000
Venture capital (Series B)
ARCH Venture Partners
,
Invus
,
Biotechnology Value Fund
,
+7
Autobahn Therapeutics Raises $76 Million To Develop Therapies For CNS Disorders
Pulse 2.0
12 Mar
2020
Kymera Therapeutics
$102,000,000
Venture capital (Series C)
Redmile Group
,
BlackRock
,
Wellington Management
,
+4
Kymera Therapeutics Raises $102M in Series C Financing
FinSMEs
15 May
2019
Phathom Pharmaceuticals
$90,000,000
Venture capital
Greenspring Associates
,
RA Capital Management
,
Frazier Healthcare Partners
,
+6
30 Apr
2019
Vividion Therapeutics
$82,000,000
Venture capital (Series B)
Cardinal Partners
,
Celgene
,
Versant Ventures
,
+7
20 Dec
2018
Relay Therapeutics
$400,000,000
Venture capital (Series C)
Foresite Capital
,
Alexandria Venture
,
Perceptive Advisors
,
+7
21 May
2018
Rain Therapeutics
$18,400,000
Venture capital (Series A)
Perceptive Advisors
,
Biotechnology Value Fund
,
UniServices Limited’s Investors Fund
Rain Therapeutics scores $18 million Series A round for lung cancer drug
MedCity News
14 Dec
2017
Relay Therapeutics
$63,000,000
Venture capital (Series B)
Alexandria Venture
,
EcoR1 Capital
,
Third Rock Ventures
,
+4
22 Sep
2017
Realm Therapeutics, Inc.
$26,000,000
Post-IPO equity
RA Capital Management
,
Abingworth
,
OrbiMed
,
+2
16 Aug
2017
Molecular Templates
$60,000,000
Post-IPO equity
Perceptive Advisors
,
Longitude Capital
,
Takeda Pharmaceutical
,
+2
https://www.bizjournals.com/austin/news/2017/08/16/austin-biotech-company-lands-on-nasdaq-with-fresh.html?ana=twt
bizjournals
+1
06 May
2016
ViewPoint Therapeutics
$4,000,000
Venture capital (Series A)
Asset Management Ventures (AMV)
,
Mission Bay Capital
,
Biotechnology Value Fund
,
+3
ViewPoint Therapeutics Closes $4M Series A Financing
FinSMEs
07 Jan
2014
Blueprint Medicines
$25,000,000
Venture capital (Series B)
Fidelity Biosciences
,
Third Rock Ventures
,
Casdin Capital
,
+2
03 Sep
2013
Evotec
$40,000,000
Venture capital
Biotechnology Value Fund
